Kashiv Biosciences has submitted its Biologics License Applications (BLA) for ADL-018 as a biosimilar to reference product XOLAIR® (omalizumab) to the U.S. Food and Drug Administration (FDA) The ...
Sleeper Markets LLC filed a civil case against the Commodity Trading and Futures Commission (CFTC) and its acting chair Caroline Pham on Monday. The suit claims that the CFTC unlawfully blocked ...
For nearly three years, prospective business owners have eagerly waited for the date they could join Rhode Island’s budding retail cannabis market. That day is now here. At the start of the Cannabis ...
The city of Madison is making it easier to get a required dog or cat license with just a few keystrokes. The new online service was announced Tuesday by Madison City Treasurer Dave Gawenda in a news ...
The US regulator said the initial submissions from the company - which has just announced plans to go public - for a licence to build and operate four Westinghouse AP1000 reactors in Texas contain ...
Prior to installation, please see the AST Docsite for detailed configuration, troubleshooting (REST changes, HIGH CPU on control plane) info, etc. See the F5 Application Study Tool Labs for an ...
Ripple has released the first volume of its OCC banking license application, taking a formal step to increase its financial infrastructure. The firm proposes its National Trust Bank, with its ...
This site displays a prototype of a “Web 2.0” version of the daily Federal Register. It is not an official legal edition of the Federal Register, and does not replace the official print version or the ...
GUANGZHOU, China, July 16, 2025 /PRNewswire/ -- Bio-Thera Solutions, Ltd (688177:SH), a commercial-stage biopharmaceutical company developing a pipeline of innovative therapies and biosimilars, today ...
Please provide your email address to receive an email when new articles are posted on . This is the first biologics license application submitted for a gene-agnostic retinal disease gene therapy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results